DHR vs MELI: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and MercadoLibre, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
MercadoLibre, Inc. · Consumer Cyclical
$1,828.94
+25.8% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MELI |
| Current Price |
$221.12 |
$1,828.94 |
| Fair Value Estimate |
$286.52 |
$2,300.00 |
| Upside to Fair Value |
+29.6%
|
+25.8%
|
| Market Cap |
$155.4B |
$92.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
33.0x
|
| Price / Sales |
6.2x
|
2.6x
|
| Price / FCF |
28.5x
|
7.4x
|
| Revenue Growth YoY |
+5.5%
|
+49.8%
|
| Gross Margin |
58.5%
|
42.7%
|
| Operating Margin |
20.4%
|
8.3%
|
| Return on Equity |
7.7%
|
26.5%
|
| Dividend Yield |
0.65% |
0% |
| FCF Yield |
3.51%
|
13.44%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
MercadoLibre operates Latin America's leading ecommerce marketplace alongside Mercado Pago payments, credit, logistics, advertising and loyalty products, creating a broad ecosystem with meaningful network effects and cross-sell. Business momentum remains strong: revenue and financial income grew 49.8% year over year in the most recent quarter to $10.169 billion, GMV increased 44%, TPV rose 56%, a…
Accumulation Zones
| Metric |
DHR |
MELI |
| Zone Low |
$214.89 |
$1,725.00 |
| Zone High |
$243.54 |
$1,955.00 |
| In Buy Zone? |
Yes
|
Yes
|